NON-HODGKIN LYMPHOMA
Clinical trials for NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exercise-Powered immune cells take on leukemia in first human trial
Disease control Not yet recruitingThis early-stage study tests whether donor immune cells collected after exercise can better prevent or treat leukemia relapse in patients who had a stem cell transplant. About 94 participants with various blood cancers will receive these special cells either to prevent relapse or…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Immune cell army targets Hard-to-Treat lymphoma
Disease control Not yet recruitingThis early-phase trial tests a new treatment for people with B-cell non-Hodgkin lymphoma that has not responded to at least two prior therapies. Participants receive donor immune cells (NK cells) along with two antibody drugs (rituximab and tafasitamab) to help the body fight the…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Exercise may turn back the clock for blood cancer survivors
Knowledge-focused Not yet recruitingThis study looks at whether a special exercise program can help older adults who have survived blood cancers like leukemia or lymphoma age more slowly. Researchers want to find out how much and what type of exercise works best. About 180 people aged 50 and older will take part, a…
Matched conditions: NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC